Mecastrin (Melatonin)

Mecastrin (melatonin) is used to address disorders of the sleep‑wake cycle.

• Insomnia: reduces sleep onset latency and improves overall sleep quality.
• Jet lag: helps synchronize circadian rhythms after rapid time‑zone travel.
• Shift work disorder: supports adaptation to irregular work schedules and promotes daytime alertness.

• Melatonin acts as an agonist at MT1 and MT2 receptors in the suprachiasmatic nucleus, mimicking the endogenous hormone that signals darkness. Activation of these receptors modulates circadian rhythm signaling, facilitating the transition to sleep and enhancing the stability of the sleep‑wake cycle without directly inducing sedation.

Mecastrin may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Headache: mild to moderate discomfort often resolving without intervention.
• Dizziness: sensation of light‑headedness, typically short‑lived.
• Daytime sleepiness: residual drowsiness after nighttime use.
• Nausea: mild stomach upset.
• Vivid dreams: unusually intense or memorable dreaming.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or difficulty breathing.
• Severe depression or mood changes: rare worsening of depressive symptoms.
• Seizures: extremely uncommon but reported in susceptible individuals.
• Hormonal effects: potential impact on reproductive hormone balance in rare cases.
• Blood pressure changes: occasional hypotension or hypertension.

Before using Mecastrin, consider the following safety measures.

• Pregnancy: consult a healthcare professional; safety data are limited.
• Breastfeeding: use with caution; melatonin may pass into breast milk.
• Underlying medical conditions: assess risks in patients with epilepsy, depression, or autoimmune disorders.
• Concomitant CNS depressants: monitor for additive sedation when combined with alcohol or sedative medications.
• Drug interactions: review potential interactions outlined in the interactions section.
• Store at ambient temperature: keep in the original container, protect from moisture and light.

Mecastrin can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): may increase bleeding risk.
• Immunosuppressants (e.g., cyclosporine): may reduce melatonin efficacy.
• CYP1A2 inhibitors (e.g., fluvoxamine): may raise melatonin plasma levels.

Moderate Interactions (Monitor Closely):\n- CNS depressants (e.g., benzodiazepines): additive sedation potential.

• Antihypertensives: possible enhancement of blood‑pressure‑lowering effect.